Cambridge Trust’s Stride LRN Stock Holding History

Cambridge Trust’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24	Closed	-$1K	–	1056
2021 Q4	$1K	Buy	+24	New	+$828	﹤0.01%	1005

Other funds holding LRN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Cambridge Trust's LRN Position: Q1 2022 in Review

Cambridge Trust sold out of Stride (LRN) in Q1 2022, closing a stake of 24 shares — an estimated $1K sold.

Cambridge Trust first reported a position in LRN in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 198 funds tracked by Wall St. Rank hold LRN as of Q1 2022.

Cambridge Trust reported no remaining Stride position as of Q1 2022 after selling out during the quarter.
Cambridge Trust sold 24 Stride shares in Q1 2022, an estimated $1K.
Cambridge Trust first reported a position in Stride in Q4 2021 and held it in 1 quarter.
Cambridge Trust's Stride position peaked at $1K in Q4 2021.
198 funds tracked by Wall St. Rank held Stride as of Q1 2022.

Based on Cambridge Trust's 13F filing for Q1 2022, filed 12 May 2022.